Login / Signup

Two Different 1-Week Quadruple Therapies Given Back-to-Back Consecutive Therapy for Difficult-to-Treat Helicobacter pylori Infection: A Pilot Study.

Jing LiuChao-Ran JiYue-Yue LiChen QiaoJun-Nan HuMeng WanMin-Juan LinBo-Shen LinJuan WangJing ZhaLi-Xiang LiXiu-Li Zuo
Published in: Clinical and translational gastroenterology (2021)
Consecutive therapy, including amoxicillin, tetracycline, and furazolidone, achieved a good eradication rate (>90%), with desirable compliance and tolerability in difficult-to-treat H. pylori infection.
Keyphrases
  • helicobacter pylori infection
  • helicobacter pylori
  • placebo controlled
  • open label
  • double blind
  • stem cells
  • clinical trial
  • randomized controlled trial